The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 randomised study evaluating the addition of low-dose nivolumab to palliative chemotherapy in head and neck cancer.
 
Vijay Maruti Patil
Research Funding - AstraZeneca (Inst); Eisai Germany (Inst); Intas (Inst); Johnson & Johnson/Janssen (Inst); NATCO Pharma (Inst); Novartis (Inst)
 
Vanita Noronha
Research Funding - Amgen (Inst); AstraZeneca (Inst); Dr. Reddy's Laboratories (Inst); Intas (Inst); Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology
 
Nandini Sharrel Menon
No Relationships to Disclose
 
Atanu Bhattacharjee
No Relationships to Disclose
 
Suman Kumar
No Relationships to Disclose
 
Nilendu Purandare
No Relationships to Disclose
 
Archi Agrawal
No Relationships to Disclose
 
Ameya Puranik
No Relationships to Disclose
 
Kavita Prakash Nawale
No Relationships to Disclose
 
Shweta Jogdhankar
No Relationships to Disclose
 
Mitali Alone
No Relationships to Disclose
 
Rupali Tambe
No Relationships to Disclose
 
Riddhi Sawant
No Relationships to Disclose
 
Devanshi Kalra
No Relationships to Disclose
 
Sachin Babanrao Dhumal
No Relationships to Disclose
 
Shripad Dinanath Banavali
No Relationships to Disclose
 
Kumar Prabhash
Research Funding - Alkem Laboratories (Inst); BDR Pharmaceutics (Inst); Biocon (Inst); Dr. Reddy's Laboratories (Inst); Fresenius Kabi (Inst); NATCO Pharma (Inst); Roche (Inst)